2012-5632. Agency Information Collection Activities; Announcement of Office of Management and Budget Approval; Substantiation for Dietary Supplement Claims Made Under the Federal Food, Drug, and Cosmetic Act  

  • Start Preamble

    AGENCY:

    Food and Drug Administration, HHS.

    ACTION:

    Notice.

    SUMMARY:

    The Food and Drug Administration (FDA) is announcing that a collection of information entitled “Substantiation for Dietary Supplement Claims Made Under the Federal Food, Drug, and Cosmetic Act” has been approved by the Office of Management and Budget (OMB) under the Paperwork Reduction Act of 1995.

    Start Further Info

    FOR FURTHER INFORMATION CONTACT:

    Denver Presley, II, Office of Information Management, Food and Drug Administration, 1350 Piccard Dr., PI50-400B, Rockville, MD 20850, 301-796-3793.

    End Further Info End Preamble Start Supplemental Information

    SUPPLEMENTARY INFORMATION:

    On August 30, 2011, the Agency submitted a proposed collection of information entitled ” Substantiation for Dietary Supplement Claims Made Under the Federal Food, Drug, and Cosmetic Act” to OMB for review and clearance under 44 U.S.C. 3507. An Agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB control number. Start Printed Page 14022OMB has now approved the information collection and has assigned OMB control number 0910-0626. The approval expires on February 28, 2015. A copy of the supporting statement for this information collection is available on the Internet at http://www.reginfo.gov/​public/​do/​PRAMain.

    Start Signature

    Dated: March 2, 2012.

    Leslie Kux,

    Acting Assistant Commissioner for Policy.

    End Signature End Supplemental Information

    [FR Doc. 2012-5632 Filed 3-7-12; 8:45 am]

    BILLING CODE 4160-01-P

Document Information

Published:
03/08/2012
Department:
Food and Drug Administration
Entry Type:
Notice
Action:
Notice.
Document Number:
2012-5632
Pages:
14021-14022 (2 pages)
Docket Numbers:
Docket No. FDA-2011-N-0403
PDF File:
2012-5632.pdf